Technical Analysis for RCEL - Avita Medical Limited
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Historical RCEL trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bearish Centerline Cross | Bearish | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| 180 Bearish Setup | Bearish Swing Setup | -6.02% | |
| Calm After Storm | Range Contraction | -6.02% | |
| Narrow Range Bar | Range Contraction | -6.02% | |
| Multiple of Ten Bearish | Other | -6.02% | |
| Outside Day | Range Expansion | -6.02% |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
- Sector: Healthcare
- Industry: Medical Devices
Avita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients 18 years and older. The company has a preclinical research collaboration with the University of Colorado School of Medicine to establish and explore development of a spray-on treatment for patients with epidermolysis bullosa. The company is based in Valencia, California.
Medicine Clinical Medicine Rare Diseases Healthcare Professionals Regenerative Medicine Platform Technology Burns Genodermatoses Injuries Wound Skin Chronic Wounds Epidermolysis Bullosa
Medicine Clinical Medicine Rare Diseases Healthcare Professionals Regenerative Medicine Platform Technology Burns Genodermatoses Injuries Wound Skin Chronic Wounds Epidermolysis Bullosa
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 153.55 |
| 52 Week Low | 20.0 |
| Average Volume | 75,889 |
| 200-Day Moving Average | 38.17 |
| 50-Day Moving Average | 32.95 |
| 20-Day Moving Average | 35.88 |
| 10-Day Moving Average | 41.45 |
| Average True Range | 12.36 |
| ADX | 37.75 |
| +DI | 15.27 |
| -DI | 72.93 |
| Chandelier Exit (Long, 3 ATRs ) | 116.48 |
| Chandelier Exit (Short, 3 ATRs ) | 63.07 |
| Upper Bollinger Band | 89.54 |
| Lower Bollinger Band | -17.79 |
| Percent B (%b) | 0.42 |
| BandWidth | 299.16 |
| MACD Line | -0.06 |
| MACD Signal Line | 1.92 |
| MACD Histogram | -1.9839 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 29.46 | ||||
| Resistance 3 (R3) | 29.44 | 28.71 | 29.10 | ||
| Resistance 2 (R2) | 28.71 | 28.16 | 28.72 | 28.98 | |
| Resistance 1 (R1) | 28.00 | 27.82 | 27.64 | 28.02 | 28.86 |
| Pivot Point | 27.27 | 27.27 | 27.08 | 27.28 | 27.27 |
| Support 1 (S1) | 26.56 | 26.72 | 26.20 | 26.58 | 25.74 |
| Support 2 (S2) | 25.83 | 26.38 | 25.84 | 25.62 | |
| Support 3 (S3) | 25.12 | 25.83 | 25.50 | ||
| Support 4 (S4) | 25.14 |
